Andrew L. Pearlman
2013
In 2013, Andrew L. Pearlman earned a total compensation of $1M as Former President and Chief Executive Officer (Former Principal Executive Officer at Medgenics, a 143% increase compared to previous year.
Compensation breakdown
| Option Awards | $120,428 |
|---|---|
| Salary | $228,373 |
| Other | $699,879 |
| Total | $1,048,680 |
Pearlman received $699.9K in other compensation, accounting for 67% of the total pay in 2013.
Pearlman also received $120.4K in option awards and $228.4K in salary.
Rankings
In 2013, Andrew L. Pearlman's compensation ranked 6,387th out of 12,286 executives tracked by ExecPay. In other words, Pearlman earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,387 out of 12,286 | 48th |
Division Manufacturing | 2,239 out of 4,612 | 52nd |
Major group Chemicals And Allied Products | 667 out of 1,466 | 55th |
Industry group Drugs | 483 out of 1,160 | 58th |
Industry Biological Products, Except Diagnostic Substances | 77 out of 200 | 62nd |
Source: SEC filing on March 11, 2014.
Pearlman's colleagues
We found six more compensation records of executives who worked with Andrew L. Pearlman at Medgenics in 2013.
2013
Michael Cola
Medgenics
Chief Executive Officer
2013
Garry Neil
Medgenics
Chief Scientific Officer
2013
John Leaman
Medgenics
Chief Financial Officer
2013
Clarence Dellio
Medgenics
Chief Operating Officer
2013
Marvin Garovoy
Medgenics
Chief Medical Officer
2013
Phyllis Bellin
Medgenics